Suppr超能文献

光动力疗法的新方向

New directions in photodynamic therapy.

作者信息

Gudgin Dickson E F, Goyan R L, Pottier R H

机构信息

Department of Chemistry and Chemical Engineering, The Royal Military College of Canada, P.O. Box 17000, Station Forces, Kingston, Ontario, Canada K7K 7B4.

出版信息

Cell Mol Biol (Noisy-le-grand). 2002 Dec;48(8):939-54.

Abstract

Photodynamic therapy (PDT), a treatment approach that makes use of a photosensitizer to generate a localized toxic species in diseased tissue, has recently become an approved treatment modality. So far, however, only a handful of photosensitizers have received regulatory approval and for a small number of diseases. This chapter outlines the major limitations of PDT and speculates on the possible improvements that are required in order to advance PDT to a front line therapy. Seven areas of improvements are discussed: drug selectivity, drug delivery, light delivery, combination therapies, pigmented tumors, other potential uses, and protocol optimization. For each area, current limitations are discussed, and further required studies are recommended.

摘要

光动力疗法(PDT)是一种利用光敏剂在病变组织中产生局部毒性物质的治疗方法,最近已成为一种获批的治疗方式。然而,到目前为止,只有少数光敏剂获得了监管批准,且仅用于少数几种疾病。本章概述了光动力疗法的主要局限性,并推测了为将光动力疗法推进到一线治疗所需的可能改进措施。讨论了七个改进领域:药物选择性、药物递送、光递送、联合疗法、色素性肿瘤、其他潜在用途和方案优化。针对每个领域,讨论了当前的局限性,并推荐了进一步所需的研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验